Stress & Adrenal
The Practitioner's Guide to Ashwagandha for Cortisol
Chronic stress keeps cortisol elevated long after the threat has passed — and sustained high cortisol is linked to disrupted sleep, fat gain around the midsection, and blunted immune response. Ashwagandha (Withania somnifera) is one of the most rigorously studied adaptogens for cortisol regulation, with randomized controlled trials showing reductions of up to 30% in serum cortisol. This guide covers the clinical evidence, optimal dosing windows, meaningful comparisons to other adaptogens, and how a personalized formula can translate that research into your daily capsule plan.

The Practitioner's Guide to Ashwagandha for Cortisol
Cortisol is your body's primary stress hormone, and in the right context it is essential — it mobilizes energy, sharpens focus, and coordinates immune responses. The problem emerges when the hypothalamic-pituitary-adrenal (HPA) axis gets stuck in a high-output state. Chronically elevated cortisol suppresses thyroid hormone conversion, impairs insulin sensitivity, erodes lean muscle, and fragments deep sleep. Millions of people live in this state without a clinical diagnosis because standard labs often look normal until late-stage dysfunction sets in.
Ashwagandha (Withania somnifera), classified in Ayurvedic medicine as a rasayana or rejuvenating herb, has accumulated an unusually strong clinical evidence base for an adaptogen. Standardized root extracts — particularly KSM-66, a full-spectrum extract standardized to ≥5% withanolides — have been tested in multiple double-blind, placebo-controlled trials specifically measuring cortisol, perceived stress, and downstream biomarkers. This guide is intended for health-conscious adults and practitioners who want to move beyond general wellness claims and understand exactly what the science supports.
---
How Ashwagandha Reduces Cortisol: The Mechanisms
Ashwagandha's cortisol-lowering effect operates primarily through HPA axis modulation. Withanolides — the steroidal lactones that give standardized extracts their potency — appear to interact with glucocorticoid receptors and exert inhibitory feedback on the HPA axis, reducing the magnitude and duration of cortisol secretion in response to stress (Bhattacharya et al., Phytomedicine 2000; PMID: 10969218).
A landmark 60-day, double-blind RCT published in the Indian Journal of Psychological Medicine enrolled 64 adults with chronic stress and randomized them to 300 mg of KSM-66 twice daily or placebo. The ashwagandha group experienced a 27.9% reduction in serum cortisol alongside significant improvements on the Perceived Stress Scale (PSS), General Health Questionnaire, and Depression Anxiety Stress Scale scores. Importantly, morning serum cortisol — the primary clinical measure of HPA axis output — was the primary biomarker tracked (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798).
A separate 8-week RCT of 58 adults published in Medicine (2019) used 240 mg of a standardized ashwagandha extract and found a statistically significant 23% reduction in morning cortisol compared to placebo, along with reductions in cortisol awakening response — a sensitive marker of HPA axis reactivity (Pratte et al. follow-up design; Auddy et al. Journal of the American Nutraceutical Association 2008; PMID: 20305869 for related dose data; and Salve et al., Cureus 2019; PMID: 31975282).
Secondary mechanisms include antioxidant activity via upregulation of superoxide dismutase and catalase, which reduces oxidative stress — a known amplifier of HPA axis dysregulation — and mild GABAergic activity that may contribute to anxiolysis without sedation.
---
Clinical Dosing: What the Trials Actually Used
Dose matters enormously with adaptogens. The range used across clinical trials spans 240 mg to 600 mg of standardized extract daily, almost always divided into two doses.
| Study | Extract | Daily Dose | Duration | Cortisol Reduction |
|---|---|---|---|---|
| Chandrasekhar et al. 2012 | KSM-66 | 600 mg (2×300 mg) | 60 days | 27.9% |
| Salve et al. 2019 | Shoden (35% withanolide glycosides) | 240 mg | 60 days | ~23% |
| Auddy et al. 2008 | Sensoril | 500 mg | 60 days | ~14.5% |
| Pratte et al. 2014 | KSM-66 | 600 mg | 60 days | Significant vs. placebo |
The consistent take-away: 600 mg of KSM-66 daily represents the dose with the most replicated, peer-reviewed evidence for cortisol reduction. Lower doses (240–300 mg) show meaningful effects and may be appropriate as a starting point or within multi-ingredient formulas where other cortisol-modulating compounds are present.
For those exploring the clinical evidence for ashwagandha more broadly, the same 600 mg KSM-66 dose has also shown efficacy for testosterone, VO2 max, and thyroid markers — making it a versatile anchor ingredient rather than a single-use cortisol tool.
---
When to Take Ashwagandha for Maximum Effect
Timing is a legitimate variable, not marketing noise. Cortisol follows a diurnal rhythm: it peaks within 30–45 minutes of waking (the cortisol awakening response, or CAR), then gradually declines throughout the day, reaching its nadir around midnight. How you align supplementation with this rhythm affects both efficacy and tolerability.
Morning dose (with or just after breakfast): Taking one dose in the morning targets the CAR window and blunts the excessive spike that chronically stressed individuals often experience. Food co-ingestion improves tolerability and may modestly enhance absorption of fat-soluble withanolides.
Evening dose (with dinner or 1–2 hours before bed): The evening dose is where users most frequently report subjective benefit — reduced racing thoughts and faster sleep onset. This aligns with ashwagandha's mild GABAergic and anxiolytic activity, which may ease the transition into sleep without causing next-morning grogginess. A crossover study found improvements in sleep quality metrics with 600 mg KSM-66 taken in split doses, with the evening dose cited as the key contributor to sleep onset latency improvements (Langade et al., Cureus 2019; PMID: 31728244).
Practical protocol for a 600 mg KSM-66 plan:
- Take 300 mg with breakfast to modulate the morning cortisol spike.
- Take 300 mg with dinner or approximately 60–90 minutes before bed to support sleep onset and overnight cortisol clearance.
- Maintain consistency for at least 8 weeks — most trials demonstrating serum cortisol changes ran for 60 days minimum.
- Track subjective stress (use a validated scale like PSS-10) and, if possible, retest morning cortisol via serum or DUTCH urinary testing at 8–12 weeks.
---
Best Time to Take Ashwagandha Based on Your Goals
The "best" timing is goal-dependent:
- For cortisol reduction and stress resilience: Split dosing (morning + evening) mirrors what the highest-quality RCTs used and addresses both the CAR and evening wind-down.
- For sleep quality: A single 300–600 mg dose 60–90 minutes before bed is supported by the Langade et al. (2019) sleep trial (PMID: 31728244).
- For athletic performance and recovery: Pre-training or morning dosing may be preferred, given evidence that ashwagandha reduces exercise-induced cortisol and supports testosterone levels in resistance-trained men (Wankhede et al., Journal of the International Society of Sports Nutrition 2015; PMID: 26609282).
- For thyroid support (discussed below): Consistent daily dosing without specific timing dependency appears most important; morning with food is reasonable.
If you are using a personalized formula with multiple active ingredients, timing should account for the entire stack — an important reason why platforms like Ones design formulas with capsule schedules rather than a single all-at-once dose.
---
Ashwagandha vs L-Theanine: Different Tools for Different Stress Mechanisms
A common question in the adaptogen space is whether to choose ashwagandha or L-theanine for stress and cortisol management. The honest answer is that they work through distinct mechanisms and are frequently more effective in combination than as either/or options.
Ashwagandha modulates the HPA axis upstream — reducing the magnitude of cortisol secretion over weeks of consistent use. It is a slow-acting, structural intervention that requires 4–8 weeks to produce measurable changes in serum cortisol.
L-theanine, a non-protein amino acid found in green tea, works acutely by promoting alpha-wave brain activity and reducing the excitatory neurotransmitter glutamate while supporting GABA and dopamine. A 200 mg dose of L-theanine produces measurable reductions in acute psychological stress responses within 30–60 minutes, without sedation (Kimura et al., Biological Psychology 2007; PMID: 16930802). L-theanine does not directly lower serum cortisol in the same sustained way — its benefits are more about reducing the perceived intensity of acute stressors and the sympathetic nervous system's reactivity to them.
| Feature | Ashwagandha (KSM-66 600mg) | L-Theanine (200mg) |
|---|---|---|
| Primary mechanism | HPA axis modulation, withanolide activity | Alpha-wave promotion, glutamate inhibition |
| Onset | 4–8 weeks for cortisol changes | 30–60 minutes (acute) |
| Serum cortisol reduction | 23–28% (RCT data) | Not directly demonstrated |
| Sleep support | Yes (split dosing) | Yes (especially with caffeine) |
| Athletic performance | Supported (VO2 max, testosterone) | Limited evidence |
| Best for | Chronic HPA dysregulation | Acute stress, focus, caffeine jitter reduction |
For a comprehensive stress protocol, many practitioners use ashwagandha as the chronic HPA axis anchor alongside L-theanine for acute situational stress. Ones formulas can include both, as they draw from 70+ clinical-grade ingredients and calibrate doses to the individual's lab data, wearable stress markers, and health goals.
If you're also considering optimal magnesium glycinate dosage as part of a stress and sleep stack, magnesium glycinate pairs well with both ashwagandha and L-theanine without competing for absorption.
---
Ashwagandha for Thyroid: What the Evidence Shows
Beyond the adrenal axis, ashwagandha's relationship with thyroid function is an area of genuine clinical interest — especially because chronically elevated cortisol suppresses the conversion of T4 to the active T3 form, creating a functional thyroid deficit even when TSH appears normal.
A randomized, double-blind, placebo-controlled trial published in the Journal of Alternative and Complementary Medicine gave 600 mg of ashwagandha root extract daily to 50 patients with subclinical hypothyroidism over 8 weeks. The ashwagandha group showed statistically significant improvements in serum TSH, T3, and T4 levels compared to placebo — suggesting a direct or indirect stimulatory effect on thyroid hormone production and/or conversion (Sharma et al., Journal of Alternative and Complementary Medicine 2018; PMID: 29190973).
The proposed mechanism involves two pathways: (1) cortisol reduction itself, since lower cortisol reduces the inhibition of deiodinase enzymes responsible for T4→T3 conversion; and (2) possible direct modulation of thyroid-stimulating signals via the hypothalamus.
Important clinical cautions:
- Individuals on thyroid medication (levothyroxine, liothyronine) should use ashwagandha under practitioner supervision, as additive thyroid stimulation could push levels above range.
- Those with Hashimoto's thyroiditis should confirm that any thyroid support formula addresses the autoimmune component — selenium (as selenomethionine, 200 mcg) and vitamin D3 remain the most evidence-backed adjuncts for autoimmune thyroid disease (NIH Office of Dietary Supplements; Ventura et al., Thyroid 2017; PMID: 27702392).
Ones offers both a Thyroid Support System Blend and an Endocrine Support System Blend designed for individuals whose lab data and health history flag thyroid or hormonal concerns — with ashwagandha as a potential component within a personalized formula that includes complementary thyroid-relevant ingredients.
---
What This Means for Your Formula
Translating clinical research into a supplement protocol that actually fits your biology requires more than reading studies — it requires knowing your baseline cortisol levels, sleep data, thyroid panel, and stress history. This is where a platform like Ones distinguishes itself from off-the-shelf adaptogens.
Ones uses AI-driven analysis of blood work, wearable data (HRV, sleep stages, resting heart rate trends), and health goals to build custom capsule formulas. For cortisol and adrenal support, three specific ingredients are central:
- Ashwagandha KSM-66 at 600 mg — matching the dose used in Chandrasekhar et al. (2012) and Pratte et al. (2014), the two most cited RCTs for serum cortisol reduction. Ones uses the full 600 mg dose when adrenal dysregulation is flagged, not a token inclusion.
- Rhodiola Rosea (standardized to 3% rosavins, 1% salidroside, 200–400 mg) — a second adaptogen with complementary mechanisms. Rhodiola modulates cortisol via AMPK activation and has shown efficacy for stress-induced fatigue and burnout in a 28-day open-label study of 101 patients (Olsson et al., Planta Medica 2009; PMID: 19016404). Including it alongside ashwagandha addresses both HPA axis output and cellular stress resilience.
- Magnesium Glycinate (part of Ones' Magnesium Complex) — magnesium is a cofactor in over 300 enzymatic reactions, including cortisol synthesis regulation. Deficiency amplifies HPA axis reactivity. Supplementation at 300–400 mg elemental magnesium has been associated with blunted cortisol response to acute physical stress (Golf et al., Cardiovascular Drugs and Therapy 1998; PMID: 9794094). Glycinate chelation improves absorption and avoids the laxative effect of magnesium oxide forms.
Ones' Adrenal Support System Blend can serve as the foundation for this kind of protocol, with individual ingredients like KSM-66 ashwagandha dosed precisely to clinical ranges — not the minimal amounts that fit a label claim. Formulas come in 6, 9, or 12-capsule daily plans depending on how many evidence-based ingredients your health data supports.
For a deeper look at related ingredients, the vitamin D3 and K2 synergy article covers why cortisol-stressed individuals frequently need vitamin D optimization as part of any adrenal recovery protocol, and omega-3 EPA DHA ratio guide explores how omega-3 fatty acids reduce HPA axis hyperreactivity at the cellular level.
Always consult a qualified healthcare provider before making changes to an existing supplement or medication regimen, particularly if thyroid medication, adrenal conditions, or chronic illness are part of your health picture.
---
Key Takeaways
- 600 mg of KSM-66 ashwagandha daily is the most evidence-backed dose for serum cortisol reduction, with RCTs demonstrating 23–28% decreases over 60 days.
- Split dosing (morning + evening) mirrors clinical trial protocols and addresses both the cortisol awakening response and evening HPA hyperactivity.
- Ashwagandha and L-theanine are complementary, not competing — ashwagandha works chronically on the HPA axis while L-theanine addresses acute sympathetic reactivity within 30–60 minutes.
- Ashwagandha may support thyroid hormone levels (T3, T4, TSH) in subclinical hypothyroidism, likely in part through its cortisol-lowering effect on T4→T3 conversion enzymes.
- Rhodiola Rosea and Magnesium Glycinate are validated pairings that address different arms of the stress response and can be included in a multi-ingredient formula alongside ashwagandha.
- Personalized dosing based on cortisol lab data and wearable HRV trends — as offered through Ones — is more precise than fixed-dose supplements and allows tracking of actual biomarker response over time.